{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:06:29Z","timestamp":1780509989985,"version":"3.54.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.autrev.2018.02.004","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T09:45:34Z","timestamp":1525340734000},"page":"727-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review"],"prefix":"10.1016","volume":"17","author":[{"given":"Giorgia","family":"Martini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Fadanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Agazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Vittadello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Meneghel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Zulian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2018.02.004_bb0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/bjd.15001","article-title":"The molecular pathogenesis of morphoea: from genetics to future treatment targets","volume":"177","author":"Saracino","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0010","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.autrev.2017.07.019","article-title":"Role of anti-receptor autoantibodies in pathophysiology of scleroderma","volume":"16","author":"Berger","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.02.004_bb0015","first-page":"73","article-title":"The epidemiology of morphea (localized scleroderma) in Olmsted County 1960\u20131993","volume":"24","author":"Peterson","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0020","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0889-857X(02)00010-8","article-title":"Scleroderma in children and adolescents","volume":"28","author":"Murray","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2018.02.004_bb0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-3476(00)90056-8","article-title":"Methotrexate and corticosteroid therapy for pediatric localized scleroderma","volume":"136","author":"Uziel","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2018.02.004_bb0030","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.30264","article-title":"Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial","volume":"63","author":"Zulian","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.02.004_bb0035","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1365-2133.2006.07497.x","article-title":"Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children","volume":"155","author":"Weibel","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0040","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/rheumatology\/kep244","article-title":"Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil","volume":"48","author":"Martini","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2018.02.004_bb0045","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrrheum.2009.159","article-title":"Resolution of pansclerotic morphea after treatment with antithymocyte globulin","volume":"5","author":"Song","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0050","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/ijd.12387","article-title":"Imatinib: a novel treatment approach for generalized morphea","volume":"53","author":"Coelho-Macias","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0055","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.autrev.2016.01.007","article-title":"Systemic sclerosis: an update in 2016","volume":"15","author":"Desbois","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.02.004_bb0060","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.autrev.2017.07.018","article-title":"How I treat patients with systemic sclerosis in clinical practice","volume":"16","author":"Rossi","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.02.004_bb0065","article-title":"Subcutaneous immunoglobulin for the treatment of deep morphoea in a child","author":"Yamazaki-Nakashimada","year":"2017","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2018.02.004_bb0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.autrev.2017.02.008","article-title":"Intravenous immunoglobulins in systemic sclerosis: data from a French nationwide cohort of 46 patients and review of the literature","volume":"16","author":"Sanges","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.02.004_bb0075","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.semarthrit.2016.08.018","article-title":"Early- and late-stage morphea subtypes with deep tissue involvement is treatable with Abatacept","volume":"46","author":"Adeeb","year":"2017","journal-title":"Semin Arthritis Rheum"},{"issue":"Suppl 106 (4)","key":"10.1016\/j.autrev.2018.02.004_bb0080","first-page":"211","article-title":"Tocilizumab in two children with pansclerotic morphea: a hopeful therapy for refractory cases?","volume":"35","author":"Martini","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0085","article-title":"Tocilizumab as a potential therapeutic option for children with severe, refractory juvenile localized scleroderma","author":"Lythgoe","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2018.02.004_bb0090","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.21264","article-title":"Localized scleroderma in childhood is not just a skin disease","volume":"52","author":"Zulian","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.02.004_bb0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3899\/jrheum.100447","article-title":"Influence of childhood scleroderma on physical function and quality of life","volume":"38","author":"Baildam","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0100","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jaad.2010.09.006","article-title":"A systematic review of morphea treatment and therapeutic algorithm","volume":"65","author":"Zwischenberger","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0105","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/bjd.12606","article-title":"Short- and long-term outcome of linear morphea in children","volume":"169","author":"Piram","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0110","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/bjd.12758","article-title":"Risk factors for morphea disease severity: a retrospective review of 114 paediatric patients","volume":"170","author":"Pequet","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0115","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/bjd.13514","article-title":"Disease recurrence in localized scleroderma: a retrospective analysis of 344 patients with paediatric- or adult-onset disease","volume":"172","author":"Mertens","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0120","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaad.2008.05.005","article-title":"Pediatric morphea (localized scleroderma): review of 136 patients","volume":"59","author":"Christen-Zaech","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/rheumatology\/kep361","article-title":"Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study","volume":"49","author":"Arkachaisri","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2018.02.004_bb0130","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.3899\/jrheum.081284","article-title":"The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures","volume":"36","author":"Arkachaisri","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0135","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jaad.2013.02.007","article-title":"The localized scleroderma cutaneous assessment tool: responsiveness to change in a pediatric clinical population","volume":"69","author":"Kelsey","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0140","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/bjd.14001","article-title":"Correlation of clinical tools to determine activity of localized scleroderma in paediatric patients","volume":"174","author":"Garcia-Romero","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0145","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/01.bor.0000245727.40630.c3","article-title":"Localized scleroderma","volume":"18","author":"Laxer","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0150","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/rheumatology\/41.10.1178","article-title":"Juvenile-onset localized scleroderma activity detection by infrared thermography","volume":"41","author":"Martini","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2018.02.004_bb0155","first-page":"968","article-title":"Childhood linear scleroderma: a possible role of thermography for evaluation","volume":"19","author":"Birdi","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0160","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archdermatol.2010.239","article-title":"An evaluation of long-term outcomes in adults with pediatric-onset morphea","volume":"146","author":"Saxton-Daniels","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0165","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1365-2133.2011.10600.x","article-title":"Misdiagnosis and delay in referral of children with localized scleroderma","volume":"165","author":"Weibel","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0170","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/rheumatology\/ker521","article-title":"Access to care for children and young people diagnosed with localized scleroderma or juvenile SSc in the UK","volume":"51","author":"Hawley","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2018.02.004_bb0175","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jaad.2012.01.011","article-title":"Morphea in adults and children cohort II: patients with morphea experience delay in diagnosis and large variation in treatment","volume":"67","author":"Johnson","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0180","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2133.2011.10535.x","article-title":"Relapse after systemic treatment in paediatric morphoea","volume":"166","author":"Mirsky","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0185","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3899\/jrheum.090708","article-title":"Treatment of pediatric localized scleroderma: results of a survey of north American pediatric rheumatologists","volume":"37","author":"Li","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0190","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/acr.21687","article-title":"Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma","volume":"64","author":"Li","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2018.02.004_bb0195","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jaad.2012.03.036","article-title":"A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea)","volume":"67","author":"Zulian","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0200","first-page":"1281","article-title":"Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis","volume":"22","author":"Clements","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0205","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/rheumatology\/kel446","article-title":"A new computerized method for the assessment of skin lesions in localized scleroderma","volume":"46","author":"Zulian","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2018.02.004_bb0210","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0846.2009.00371.x","article-title":"Validation of a protocol for the assessment of skin temperature and blood flow in childhood localised scleroderma","volume":"15","author":"Howell","year":"2009","journal-title":"Skin Res Technol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0215","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1002\/art.22920","article-title":"Laser Doppler flowmetry for assessing localized scleroderma in children","volume":"56","author":"Weibel","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.02.004_bb0220","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3109\/14397595.2013.844301","article-title":"High frequency ultrasound can detect improvement of lesions in juvenile localized scleroderma","volume":"24","author":"Porta","year":"2014","journal-title":"Mod Rheumatol Jpn Rheum Assoc"},{"key":"10.1016\/j.autrev.2018.02.004_bb0225","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1001\/archdermatol.2011.243","article-title":"14-MHz ultrasonography as an outcome measure in morphea (localized scleroderma)","volume":"147","author":"Nezafati","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0230","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/acr.20407","article-title":"Initial evaluation of an ultrasound measure for assessing the activity of skin lesions in juvenile localized scleroderma","volume":"63","author":"Li","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2018.02.004_bb0235","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jaad.2010.08.027","article-title":"Activity assessment in morphea using color Doppler ultrasound","volume":"65","author":"Wortsman","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0240","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2214\/AJR.07.2163","article-title":"MRI findings in deep and generalized morphea (localized scleroderma)","volume":"190","author":"Horger","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0245","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1148\/radiol.11102136","article-title":"Localized scleroderma: MR findings and clinical features","volume":"260","author":"Schanz","year":"2011","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.autrev.2018.02.004_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12969-017-0218-5","article-title":"Cone beam computed tomography for the assessment of linear scleroderma of the face","volume":"16","author":"Di Giovanni","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.autrev.2018.02.004_bb0255","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2214\/AJR.12.9335","article-title":"Response evaluation of musculoskeletal involvement in patients with deep morphea treated with methotrexate and prednisolone: a combined MRI and clinical approach","volume":"200","author":"Schanz","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.autrev.2018.02.004_bb0260","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1002\/art.38853","article-title":"Comparison of outcomes in adults with pediatric-onset morphea ans those with adult-onset morphea. A cross-sectional study from the Morphea in adults and children cohort","volume":"66","author":"Condie","year":"2014","journal-title":"Arthritis Rheum"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218301137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218301137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T13:09:47Z","timestamp":1720271387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997218301137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1568997218301137"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2018.02.004","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2018.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}